GL1X · GenesisL1 explorer

MolNFT v1 · #129498 · protein

Crystal structure of ALPHA1-antichymotrypsin variant dbs-II: a drug- binding serpin for doxorubicin

5OM7 · Alpha-1-antichymotrypsin: “Crystal structure of ALPHA1-antichymotrypsin variant dbs-II: a drug- binding serpin for doxorubicin”. X-ray diffraction, 1 ligand (DM2), 2 pockets (best druggability 0.48). MolNFT v1 #129498 on GenesisL1…

PDB
5OM7
Type
protein
Length
371 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antichymotrypsin
UniProt
P01011
Ligands
DM2
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 38% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antichymotrypsinprotein33836% helix, 37% strandP01011
BAlpha-1-antichymotrypsinprotein330% helix, 52% strandP01011

Ligands and binding sites

  • DM2 · Doxorubicin · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11060.480.8018DM2
2560.390.8117empty

Interfaces

1 interface between chains.

  • A–B · 2438 Ų buried · 33 hydrogen bonds · protein-protein

Compared structures

  • 5OM7 · Crystal structure of Alpha1-antichymotrypsin variant DBS-II: a drug-binding serpin for… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01011 · AlphaFold monomer V2.0 prediction for alpha-1-antichymotrypsin (P01011) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.